期刊文献+

赛斯平免疫抑制作用机理的探讨 被引量:1

Studies on the immunosuppressive mechanism of Cyspin
原文传递
导出
摘要 通过赛斯平对人外周血单个核细胞体外作用的研究,探讨赛斯平的免疫抑制作用及其机理。结果表明,塞斯平能显著抑制植物血凝素(PHA)诱导的T淋巴细胞增殖反应,抑制作用主要发生在早期,而且抑制强度随药物浓度增加而增强,赛斯平对PHA激活的T淋巴细胞表面白细胞介素2受体的表达呈强烈的抑制作用(P<0.001)。结果提示赛斯平能显著地抑制淋巴细胞的增殖及白细胞介素2受体的表达,具有满意的免疫抑制效果。 The influence of Cyspin on T cell activation was investigated by examining T cell proliferation and IL-2R expression. Results showed that Cyspin exerted marked inhibitory effect on PHA-induced T cell proliferation in the early phase of the process, that the inhibition effect was dose-dependent and that adding Cyspin to PHA stimulated lymphocytes led to blocking of IL2R expression(Pwt0. 001). It is suggested that the inhibitory effect of Cyspin on T cell proliferation is most probably mediated by blocking IL-2 production as well as IL-2R expression.
出处 《中华器官移植杂志》 CAS CSCD 1996年第1期23-24,共2页 Chinese Journal of Organ Transplantation
关键词 赛斯平 淋巴细胞 白细胞介素2 受体 Cyspin Hyperplasia, lymphocytes IL-2R Inhibition
  • 相关文献

同被引文献16

  • 1许贤豪.肌无力[M].北京:中国协和医科大学出版社,2003.26,48-75.
  • 2Holt DW, Mueller EA, Kovarik JM,et al. Sandimmune Neoral pharmacokinetics:impact of the new oral formulation[J]. Transpl Proc, 1995,27 : 1434.
  • 3Antonini G, Bove R, Filippini C,et al. Results of an open trial of eyelosporine in a group of steroid-dependent myasthenie subjeets[J]. Clin Neurol Neurosurg, 1990,92:317-321.
  • 4Schalke BCG, Kappos L, Dommasch D,et al. Cyclosporin A (CyA) in the treatment of myasthernia gravis (MG) : A controlled randomized double blind trial cyclosporin A/azathioprine study design and first results [J]. Muscle Nerve, 1986,9(5s) : 157.
  • 5Hartung HP. Suppression of actively induced andpassively transferred experimental allergic neuritis bycyclosporin A [J]. J Neuroimmunol, 1991, al (1)89-90.
  • 6Jolivalt CG, Howard RB, Chen LS,etal. A novel nitrie oxide seavenger in eombination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in miee[J]. J Neuroimmunol,2003, 138(1-2) : 56-64.
  • 7Mahattanakul W, Crawford TO, Griffin JW, et al.Treatment of ehornie inflammatory demyelinating polyneuropathy with eyelosporin-A [J]. J Neurol Neurosurg Psyehiat, 1996,60(2) : 185-187.
  • 8Burdmann EA, Andoh TF, Yu L,etal. Cyclosporine nephrotoxieity[J]. Semin Nephrol, 2003,23 (5): 465- 476.
  • 9O' Keefe SJ, Tamura J, Kincaid RL. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by ealeineurin[J]. Nature, 1992,357:692-694.
  • 10Faulds D, Goa KL, Benfield P. Cyclosporin A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders[J]. Drugs, 1993,45:953-1040.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部